Immune

Developing, funding and conducting clinical trials in immune tolerance

Home

An NIH-sponsored clinical trial for people with primary membranous nephropathy

 

REBOOT is currently enrolling participants in Part B

  • Home
  • About Primary MN
  • About REBOOT
  • Am I Eligible?
  • Study Locations

Am I Eligible?

You may be eligible to participate in REBOOT if you:

  • Are 18 to 75 years old
  • Have been diagnosed with primary membranous neuropathy

Determine if you may be eligible to participate.

Find a REBOOT location near you.

  • About ITN
  • Other ITN Studies
  • Patient Rights & Informed Consent
  • Understanding Clinical Trials

REBOOT is being conducted by the Immune Tolerance Network and sponsored by the National Institute of Allergy and Infectious Diseases (NIH funded).

NIH
  • Home
  • About Primary MN
  • About REBOOT
  • Am I Eligible?
  • Study Locations
  • About ITN
  • Other ITN Studies
  • Patient Rights & Informed Consent
  • Understanding Clinical Trials